An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITP
Status:
Unknown status
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the efficacy of romiplostim administered at every other
week in ITP patients who attained stable platelet counts ≥ 50 x 109/L for 4 consecutive weeks
after weekly doses of romiplostim.